Management of common vulval conditions

Medical Journal of Australia

Volumn 178, Issue 8, 2003, Pages 391-395

  Welsh, Belinda M ^c   Berzins, Karen N ^a   Cook, Kathy A ^a   Fairley, Christopher K ^a,b  

^a MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MERCY HOSPITAL FOR WOMEN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIFUNGAL AGENT; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; BORIC ACID; CLOTRIMAZOLE; CONTRACEPTIVE AGENT; CORTICOSTEROID; DESIPRAMINE; DOXEPIN; ESTROGEN; ETHINYLESTRADIOL; FLUCONAZOLE; FLUCYTOSINE; GABAPENTIN; HYDROCORTISONE; IMIDAZOLE DERIVATIVE; IMIPRAMINE; IRRITANT AGENT; ITRACONAZOLE; KETOCONAZOLE; LIDOCAINE; METHYLPREDNISOLONE ACEPONATE; PERMANGANATE POTASSIUM; PROGESTERONE; SOAP; SPERMICIDAL AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ANAMNESIS; BEHAVIOR THERAPY; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; DERMATITIS; DIAGNOSTIC ACCURACY; DIET THERAPY; DISEASE CONTROL; DISEASE DURATION; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; GENITAL SYSTEM EXAMINATION; GYNECOLOGIC SURGERY; HEALTH SURVEY; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; LIVER TOXICITY; PHYSIOTHERAPY; PSORIASIS VULGARIS; RECURRENT INFECTION; REVIEW; SKIN BIOPSY; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; VAGINA CANDIDIASIS; VAGINITIS; VULVA DISEASE; VULVA PRURITUS; VULVA TUMOR; VULVAR VESTIBULITIS; VULVODYNIA; VULVOVAGINITIS;

EID: 0037961803     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05257.x     Document Type: Review

References (41)

1. Harlow BL, Wise LA, Stewart EG. Prevalence and predictors of chronic lower genital tract discomfort. Am J Obstet Gynecol 2001; 185: 545-550.
2. Heim LJ. Evaluation and differential diagnosis of dyspareunia. Am Fam Phys 2001; 63: 1535-1544.
3. Sobel JD. Vulvovaginitis. Dermatol Clin 1992; 10: 339-359.
4. Metts JF. Vulvodynia and vulvar vestibulitis: Challenges in diagnosis and management. Am Fam Physician 1999; 59: 1547-1556, 1561-1562.
5. Marren P, Wojnarowska F, Powell S. Allergic contact dermatitis and vulvar dermatoses. Br J Dermatol 1992; 126: 52-56.
6. Fischer GO. The commonest causes of symptomatic vulvar disease: A dermatologist's perspective. Aust J Dermatol 1996; 37: 12-18.
7. Crone AM, Stewart EJ, Wojnarowska F, et al. Aetiological factors in vulvar dermatitis. J Eur Acad Dermatol Venereol 2000; 14: 181-186.
8. Marren P, Wojnarowska F. Dermatitis of the vulva. Semin Dermatol 1996; 15: 36-41.
9. Fischer G, Spurrett B, Fischer A. The chronically symptomatic vulva: Aetiology and management. Br J Obstet Gynaecol 1995; 102: 773-779.
10. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess (Winch Eng) 2000; 4: 1-191.
11. National Health and Medical Research Council. A Guide to the Development, Implementation and Evaluation of Clinical Practice Guidelines. Canberra: NHMRC, AusInfo, 1999.
12. Gupta MA, Guptat AK. The ue of antidepressant drugs in dermatology. J Eur Acad Dermatol Venereol 2001; 15: 512-518.
13. Ringdhal EN. Treatment for recurrent vulvovaginal candidiasis. Am Fam Physician 2000; 61: 3306-3312.
14. Foxman B, Barlow R, D'Arcy H, et al. Candida vaginitis. Sex Transm Dis 2000; 27: 230-235.
15. Ferrer J. Vaginal candidosis: Epidemiological and etiological factors. Int J Gynaecol Obstet 2000; 71: S21-S27.
16. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51 (RR-6): 1-78.
17. Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000; 30: 662-678.
18. Horowitz BJ, Giaquinta D. Evolving pathogens in vulvovaginal candidiasis: Implications for patient care. J Clin Pharmacol 1992; 32: 248-255.
19. Lacour M, Zunder T, Huber R, et al. The pathogenetic significance of intestinal Candida colonization - A systematic review from an interdisciplinary and environmental medical point of view. Int J Hyg Environ Health 2002; 205: 257-268.
20. Fong IW. The value of treating the sexual partners of women with recurrent vulvovaginal candidiasis with ketoconazole. Genitourin Med 1992; 68: 174-176.
21. Denning DW. Management of genital candidiasis. BMJ 1995; 310: 1241-1244.
22. Dennerstein G. Depo Provera in the treatment of recurrent vulvovaginal candidiasis. J Reprod Med 1986; 31: 801-803.
23. Meyrick Thomas RH, Ridley CM, McGibbon DH, et al. Lichen sclerosus et atrophicus and autoimmunity - A study of 350 women. Br J Dermatol 1988; 118: 41-46.
24. Ball SB, Wojnarowska F. Vulvar dermatoses: Lichen sclerosus, lichen planus, and vulval dermatitis/lichen simplex chronicus. Semin Cutan Med Surg 1998; 17: 182-188.
25. Sinha P, Sorinola O, Luesley DM. Lichen sclerosus of the vulva. Long-term steroid maintenance therapy. J Reprod Med 1999; 44: 621-624.
26. Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc 1971; 57: 9-30.
27. Ashcroft DM, Po AL, Williams HC, et al. Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis. BMJ 2000; 320: 963-967.
28. Kaufman RH. Intraepithelial neoplasia of the vulva. Gynecol Oncol 1995; 56: 8-21.
29. Detre T, Hayashi TT, Archer DF. Management of the menopause. Ann Int Med 1978; 88: 373-378.
30. Goetsch MF. Vulvar vestibulitis: Prevalence and historic features in a general gynecologic practice population. Am J Obstet Gynecol 1991; 164: 1609-1614; discussion, 1614-116.
31. Meana M, Binik YM, Khalife S, et al. Dyspareunia: Sexual dysfunction or pain syndrome? J Nerv Ment Dis 1997; 185: 561-569.
32. Masheb RM, Nash JM, Brondolo E, et al. Vulvodynia: An introduction and critical review of a chronic pain condition. Pain 2000; 86: 3-10.
33. Fitzpatrick CC, DeLancey JOL, Elkins TE, et al. Vulvar vestibulitis and interstitial cystitis: A disorder of urogenital sinus-derived epithelium? Obstet Gynecol 1993; 81: 860-862.
34. Bergeron S, Binik YM, Khalife S, et al. Vulvar vestibulitis syndrome: Reliability of diagnosis and evaluation of current diagnostic criteria. Obstet Gynecol 2001; 98: 45-51.
35. Glazer HI, Rodke G, Swencionis C, et al. Treatment of vulvar vestibulitis syndrome with electromyographic biofeedback of pelvic floor musculature. J Reprod Med 1995; 40: 283-290.
36. Bohl TG. Vulvodynia and its differential diagnoses. Semin Cutan Med Surg 1998; 17: 189-195.
37. Ben-David B, Friedman M. Gabapentin therapy for vulvodynia. Anesth Analg 1999; 89: 1459-1460.
38. McCormack WM, Spence MR. Evaluation of the surgical treatment of vulvar vestibulitis. Eur J Obstet Gynecol Reprod Biol 1999; 86: 135-138.
39. McKay M. Dysesthetic ("essential") vulvodynia. Treatment with amitriptyline. J Reprod Med 1993; 38: 9-13.
40. Davis GD, Hutchinson CV. Clinical management of vulvodynia. Clin Obstet Gynecol 1999; 42: 221-233.
41. Eisen A. Venflaxine therapy for vulvodynia. Pain Clinic 1995; 8: 365-367.